Ganciclovir 500 MG Injection — RxCUI 310442
RxNorm drug concept · Semantic clinical drug
RxCUI 310442
Semantic clinical drug · SCD
● Current RxNorm concept 6 FDA products
6 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI310442
Official nameGanciclovir 500 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asganciclovir 500 MG (as ganciclovir sodium) Injection
FDA products mapped6
Package NDCs mapped6
Reported Medicaid activity (SDUD)274 prescriptions · 8 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Ganciclovir: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Ganciclovir is an antiviral that stops certain viruses from copying themselves. The injection form is used mainly to treat or prevent CMV (cytomegalovirus) infections — a serious v...
- Why has my doctor prescribed ganciclovir — what exactly does it do?
- The most important ones to watch for with the injection form are signs of low blood counts — things like unusual bruising, bleeding gums, persistent fever, or feeling unusually wea...
- What side effects should I actually watch out for?
🕸️ Concept Web — How Ganciclovir 500 MG Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Ganciclovir 500 MG Injection
RxCUI 310442 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Ganciclovir
4678IN
-
Ganciclovir
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ganciclovir Injection
1732140SCDF -
Ganciclovir Injectable Product
1163917SCDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Ganciclovir Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ganciclovir 500 MG
315974SCDC
-
Ganciclovir 500 MG
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ganciclovir 500 MG
SCDC · 315974 -
Ganciclovir Injection
SCDF · 1732140 -
Ganciclovir Injectable Product
SCDG · 1163917
📦 FDA Products & Package NDCs
6 products · 6 package NDCs
6 package NDCs map to RxCUI 310442 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00143-9299-10 | 10 VIAL in 1 BOX (0143-9299-10) / 10 mL in 1 VIAL (0143-929... | Ganciclovir | Hikma Pharmaceuticals USA Inc. | 2021-06-17 |
| 42023-0173-25 | 25 VIAL, SINGLE-DOSE in 1 CARTON (42023-173-25) / 10 mL in... | Ganciclovir | Endo USA, Inc. | 2016-12-06 |
| 63323-0315-10 | 25 VIAL in 1 TRAY (63323-315-10) / 10 mL in 1 VIAL (63323-3... | Ganciclovir | Fresenius Kabi USA, LLC | 2010-06-28 |
| 63323-0315-94 | 25 VIAL in 1 TRAY (63323-315-94) / 10 mL in 1 VIAL (63323-3... | Ganciclovir | Fresenius Kabi USA, LLC | 2010-06-28 |
| 70436-0089-55 | 25 VIAL in 1 CARTON (70436-089-55) / 10 mL in 1 VIAL | ganciclovir | Slate Run Pharmaceuticals, LLC | 2019-01-01 |
| 70436-0231-55 | 25 VIAL in 1 CARTON (70436-231-55) / 10 mL in 1 VIAL | ganciclovir sodium | Slate Run Pharmaceuticals, LLC | 2024-09-01 |
Observed labelers:
Fresenius Kabi USA, LLC (2) ·
Slate Run Pharmaceuticals, LLC (2) ·
Endo USA, Inc. (1) ·
Hikma Pharmaceuticals USA Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J1570 | Ganciclovir sodium injection | 6 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.